Data From Zohydro(TM) ER (hydrocodone bitartrate) Phase 3 Clinical Trial Published in Pain Medicine Demonstrates Its Benefit as a Therapeutic Option for the Management of Pain Severe Enough to Require Daily, Around-the-Clock, Long-Term Opio

[GlobeNewswire] – SAN DIEGO — Zogenix, Inc. , a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced the publication … more

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Zogenix is hiring next, click here to view